Related by context. All words. (Click for frequent words.) 68 Crohn disease 67 metastatic malignant 67 Crohn disease CD 67 CIMZIA TM certolizumab pegol 66 psoriatic arthritis PsA 66 Cimzia TM 65 recurrent glioblastoma multiforme 65 ankylosing spondylitis AS 65 lupus nephritis 65 AA Amyloidosis 65 progressive PsA 65 rheumatoid arthritis RA 65 PsA 64 adalimumab Humira 64 steroid refractory ulcerative 64 SJIA 64 leukemia AML 64 pediatric Crohn disease 64 autoantibody positive 64 efalizumab 63 Idiopathic Pulmonary Fibrosis 63 duodenal ulcer 63 Chronic lymphocytic leukemia 63 Chronic Myelogenous Leukemia CML 63 mucosal healing 63 recurrent glioblastoma 63 colitis UC 62 REMICADE ® 62 Sezary syndrome 62 relapsing remitting MS RRMS 62 infliximab therapy 62 fistulizing Crohn disease 62 Waldenstrom macroglobulinemia 62 gastrointestinal stromal tumors GIST 62 chronic urticaria 62 active PsA 62 biologic DMARD 62 intermittent dosing 62 rheumatoid arthritis RA ankylosing 62 chronic inflammatory bowel 62 atypical hemolytic uremic syndrome 62 papillary renal cell carcinoma 62 ZACTIMA 62 colorectal adenoma 62 RoACTEMRA 62 Leukemias 62 Adalimumab 62 systemic lupus erythematosus SLE 62 octreotide LAR 62 pouchitis 62 chronic thromboembolic pulmonary 62 Rheumatoid Arthritis RA 62 relapsing multiple sclerosis 62 CIMZIA TM 62 Tolvaptan 62 severe exacerbations 61 CIMZIA ™ 61 ADPKD 61 Myelodysplastic Syndrome MDS 61 paricalcitol 61 biologic therapy 61 relapsed MM 61 polymyalgia rheumatica 61 rheumatoid arthritis psoriatic arthritis 61 benign prostatic hypertrophy BPH 61 HBeAg negative 61 acromegalic patients 61 fibromyalgia syndrome 61 hypercalcemia 61 arthritis PsA 61 dual endothelin receptor antagonist 61 RRMS patients 61 immunomodulatory therapy 61 neurological manifestations 61 immune thrombocytopenic purpura 61 leukemia CLL 61 decompensated liver disease 61 SHPT 61 metastatic renal cell carcinoma 61 leukemia ALL 61 unstable angina UA 61 ara C 61 anterior uveitis 61 peritumoral brain edema 61 lupus erythematosus 61 primary immunodeficiency PI 61 hepatorenal syndrome 61 nonalcoholic steatohepatitis NASH 61 elevated serum creatinine 61 hepatic encephalopathy HE 61 refractory indolent non 61 progressive psoriatic arthritis 61 PROCRIT ® 61 ORENCIA ® 61 eosinophilic asthma 61 active ankylosing spondylitis 61 chronic immune thrombocytopenic 61 cinacalcet 60 follicular lymphoma FL 60 Irritable bowel syndrome 60 ACTEMRA TM 60 Myelofibrosis 60 Acute myeloid leukemia 60 Diabetic nephropathy 60 haematologic 60 carcinoid tumors 60 TNF Tumor Necrosis Factor 60 refractory cutaneous T 60 alemtuzumab treated 60 BARACLUDE ® 60 alefacept 60 Natalizumab 60 tegaserod 60 heavily pretreated 60 MCyR 60 AGILECT R 60 moderate ulcerative colitis 60 Irritable Bowel Syndrome IBS 60 Candida infection 60 Neovascular Age Related Macular 60 mucosal inflammation 60 symptomatic paroxysmal AF 60 juvenile idiopathic arthritis JIA 60 INSPIRE Trial Phase III 60 Certolizumab pegol 60 infliximab Remicade 60 MALT lymphoma 60 cytopenias 60 Vidaza azacitidine 60 elevated ALT 60 acute myeloid 60 Doxil ® 60 pheochromocytoma 60 Philadelphia Chromosome Positive 60 squamous histology 60 rheumatoid arthritis RA psoriatic 60 bronchial hyperresponsiveness 60 atopic dermatitis AD 60 adriamycin 60 disease GERD 60 post herpetic neuralgia PHN 60 chronic idiopathic 60 pentoxifylline 60 leucopenia 60 pancreatic neuroendocrine tumors 60 Eisenmenger syndrome 60 CYT# potent vascular disrupting 60 metastatic GIST 60 antiangiogenic therapy 60 cytogenetic responses 60 FluCAM arm 60 thymoma 60 Pemetrexed 60 Crohns disease 60 immune thrombocytopenic purpura ITP 60 superficial bladder cancer 60 crohn disease 60 acute GvHD 60 chronic lymphocytic leukemia CLL 60 EXJADE 60 rFVIIa 59 MULTAQ 59 CHOP chemotherapy 59 biliary tract cancer 59 pemphigus vulgaris 59 relapsed refractory 59 oral candidiasis 59 Interstitial cystitis 59 Teriflunomide 59 systemic lupus erythematosus 59 8mg/kg 59 chronic periodontitis 59 quetiapine Seroquel 59 Chronic Fatigue Syndrome CFS 59 non splenectomized 59 imatinib resistant 59 duodenal ulcers 59 Relapsing Remitting Multiple Sclerosis 59 hypereosinophilic syndrome 59 Hodgkin lymphoma HL 59 advanced hepatocellular carcinoma 59 vandetanib 59 riociguat 59 chronic myeloid 59 Chronic Sinusitis 59 osteoporotic vertebral compression fractures 59 TNF antagonist 59 secondary hyperparathyroidism 59 chronic eosinophilic leukemia 59 irritable bowel syndrome IBS 59 inhaled bronchodilators 59 erythropoietic 59 mycophenolate mofetil MMF 59 histologically confirmed 59 thalidomide Thalomid 59 HBeAg positive 59 refractory acute myeloid 59 ZOLINZA 59 myelodysplastic myeloproliferative diseases 59 cisplatin chemotherapy 59 Toxicities 59 Bronchiectasis 59 estramustine 59 refractory SCLC 59 Sodium oxybate 59 Ankylosing Spondylitis 59 immunocompetent 59 Tarceva erlotinib 59 nonmetastatic prostate cancer 59 chemo radiotherapy 59 T1DM 59 immunocompetent patients 59 hematologic toxicity 59 Idiopathic Pulmonary Fibrosis IPF 59 β blockers 59 receptor inhibitor 59 reflux esophagitis 59 mitoxantrone plus 59 BENICAR 59 prostate cancer CaP 59 Raptiva ® 59 gastrointestinal stromal tumor GIST 59 thyrotoxicosis 59 ANCA associated 59 ATACAND 59 purpura ITP 59 COPAXONE R 59 Ribavirin causes 59 visilizumab 59 vidofludimus 59 rheumatoid arthritis osteoarthritis ankylosing 59 Diffuse Large B 59 Combination therapy 59 generalized edema 59 pulmonary hypertension PH 59 NeuroStar TMS Therapy 59 abacavir Ziagen 59 Hepatocellular Carcinoma HCC 59 malignant pleural mesothelioma 59 DLBCL 59 recurrent NSCLC 59 TMP SMX 59 TMS Therapy 59 plaque psoriasis 59 chronic idiopathic thrombocytopenic purpura 59 severe hypersensitivity reactions 59 Mitomycin C 59 CTEPH 59 gastrointestinal GI motility disorders 59 Sevelamer 59 STELARA ™ 59 ibandronate 59 plus methotrexate 59 Severe Primary IGFD 59 generalized anxiety disorder GAD 59 receiving immunosuppressive therapy 59 MGd 59 carcinoid tumor 59 KRAS mutations occur 59 metastatic gastric 59 gastrointestinal stromal tumor 59 hepatic metastases 59 recurrent genital herpes 59 atypical Hemolytic Uremic Syndrome 59 latent celiac disease 59 DPNP 59 corticosteroid therapy 59 metastatic bladder 59 Remicade infliximab 59 discoid lupus 59 Pharmacokinetics PK 58 relapsed refractory AML 58 Traficet EN 58 HBeAg positive patients 58 EFFEXOR XR 58 patientswith 58 MGUS 58 systemic fungal infections 58 selective modulator 58 relapsed CLL 58 polyarticular 58 erlotinib Tarceva ® 58 HoFH 58 Sjogren Syndrome 58 symptomatic BPH 58 tiotropium bromide 58 Gleevec resistant 58 noninfectious uveitis 58 PREZISTA r 58 calcineurin inhibitor 58 Venous thromboembolism 58 overactive bladder OAB 58 ADHF 58 Ankylosing spondylitis 58 Etanercept 58 NAGS deficiency 58 urothelial cancer 58 smoldering multiple myeloma 58 reflux symptoms 58 Glioblastoma Multiforme 58 cutaneous melanoma 58 non metastatic osteosarcoma 58 evaluating tivozanib 58 candidemia 58 FOLPI 58 Chronic pancreatitis 58 smoldering myeloma 58 hereditary predisposition 58 lumbar disc disease 58 ß blockers 58 acne vulgaris 58 HeFH 58 deep venous thromboses 58 sunitinib malate 58 decompensated heart failure 58 cell lymphoma CTCL 58 hypercholesterolaemia 58 metastatic neuroendocrine tumors 58 C1 INH deficiency 58 cilengitide 58 sJIA 58 MabThera Rituxan 58 rituximab Rituxan 58 B Cell Lymphoma 58 acute humoral rejection 58 biochemical relapse 58 IFN beta 58 DMARD therapy 58 SSc 58 leukoencephalopathy 58 AA amyloidosis 58 QVAR R 58 relapsing remitting multiple sclerosis 58 hypophosphatemia 58 Atopic dermatitis 58 VAPRISOL 58 macrolide antibiotic 58 Amrubicin 58 RAS mutations 58 Non Alcoholic Steatohepatitis 58 Systemic Lupus Erythematosus SLE 58 TTR amyloidosis 58 acute leukemias 58 chronic GVHD 58 trastuzumab Herceptin ® 58 refractory chronic myeloid 58 Acute Myeloid Leukaemia AML 58 Primary IGFD 58 Paxil paroxetine 58 seropositive patients 58 demonstrated antitumor activity 58 ischemic colitis 58 gastro esophageal reflux disease 58 myelodysplastic syndrome MDS 58 ARIXTRA 58 diabetic gastroparesis 58 GH deficiency 58 bullous 58 CAELYX 58 reflux disease GERD 58 interstitial cystitis IC 58 Golimumab 58 Restless Legs Syndrome RLS 58 Hydroxyurea 58 Glioblastoma Multiforme GBM 58 vWD 58 idiopathic pulmonary arterial hypertension 58 ABCB1 58 TEMODAL 58 Juvenile Idiopathic Arthritis 58 invasive aspergillosis 58 gastro oesophageal reflux 58 autoimmune thyroiditis 58 Chronic sinusitis 58 Zarnestra 58 hyperphenylalaninemia HPA due 58 refractory metastatic 58 protease inhibitor PI 58 Autoimmune hepatitis 58 CP CPPS 58 oral Hycamtin 58 immunosuppressive regimen 58 adjunctive placebo 58 included exfoliative dermatitis 58 atrophic gastritis 58 relapsed ovarian cancer 58 CCyR 58 Dasatinib 58 urothelial carcinoma 58 teriflunomide 58 esophageal candidiasis 58 leukotriene receptor antagonist 58 antibody mediated rejection 58 erythematosus 58 paraganglioma 58 tacrolimus ointment 58 denileukin diftitox 58 Enzastaurin 58 thrombocytopenic 58 Kinoid 58 refractory NSCLC 58 mcg BID 58 achieved ACR# 58 Nilotinib 58 juvenile idiopathic arthritis 58 rheumatoid arthritis Crohn disease 58 hemorrhagic cystitis 58 phase IIb study 58 ritonavir boosted 58 cisplatin gemcitabine 58 Rilonacept 58 Renal impairment 58 APTIVUS r 58 inflammatory acne 58 mycophenolate mofetil 58 malignant neoplasm 58 proliferative diabetic retinopathy 58 secondary hyperparathyroidism SHPT 58 proctitis 58 idiopathic thrombocytopenic purpura ITP 58 Cimzia R 58 sargramostim 58 remission induction 58 ACEI 58 pegylated interferon alpha 58 Noxafil 58 stage IIIb IV 58 thetreatment 58 radiochemotherapy 58 gastrointestinal perforation 58 cell lymphoma ALCL 58 4mg/kg 58 Systemic lupus erythematosus SLE 58 gastro esophageal reflux 58 Xanafide 58 granulomatous 58 Navelbine ® 57 panitumumab Vectibix 57 NOMID 57 Hashimoto thyroiditis 57 FASLODEX 57 clomipramine 57 mixed hyperlipidemia 57 primary Restless Legs 57 anagrelide 57 squamous cell lung cancer 57 Myelodysplastic Syndrome 57 ARCALYST ® 57 CsA 57 salmeterol fluticasone 57 SIBO 57 LHRH receptor positive 57 endometrial hyperplasia 57 diabetic kidney 57 idiopathic PAH 57 imatinib Gleevec ® 57 endoscopic remission 57 recurrent GBM 57 Lymphocytic 57 cholinesterase inhibitor 57 Tasimelteon 57 bendamustine 57 systemic juvenile idiopathic 57 rituximab refractory 57 hyperammonemia 57 systolic dysfunction 57 bacterial prostatitis 57 chlorambucil 57 colorectal liver metastases 57 Gastritis 57 conventional DMARDs 57 posaconazole 57 lenalidomide Revlimid R 57 FUSILEV enhances 57 hypervolemic hyponatremia 57 soft tissue sarcomas 57 dasatinib Sprycel ® 57 antibody MAb 57 glatiramer acetate 57 Adjuvant chemotherapy 57 neuropsychiatric symptoms 57 Crohn Disease 57 paclitaxel Taxol 57 KETEK 57 Vitamin B# deficiency 57 refractory anaplastic astrocytoma 57 lymphoma CTCL 57 Infusion Reactions Severe 57 pemphigus 57 severe neutropenia 57 nephrotic syndrome 57 Eltrombopag 57 alkylating agent 57 decitabine 57 alkylating agents 57 Degarelix 57 primary aldosteronism 57 ULORIC 57 BoNTA 57 detectable HCV RNA 57 voriconazole 57 colorectal carcinoma 57 hyperparathyroidism 57 antihypertensive therapy 57 Asacol R 57 T2DM 57 mycosis fungoides 57 debilitating autoimmune 57 metastatic renal 57 desvenlafaxine succinate 57 somatostatin analog 57 sensory neuropathy 57 natalizumab 57 untreated celiac disease 57 KRAS mutant tumors 57 malignant lymphoma 57 Chronic Myeloid Leukemia 57 Relapsed Refractory 57 VELCADE melphalan 57 interstitial pneumonia 57 symptom flare ups 57 sertraline Zoloft 57 Cloretazine 57 Hematologic 57 ximelagatran 57 galiximab 57 Decitabine 57 metastatic lung cancer 57 Eculizumab 57 refractory AML 57 oxycodone CR 57 6 mercaptopurine 57 sorafenib Nexavar 57 tigecycline 57 invasive candidiasis 57 Sjögren syndrome 57 metastatic uveal melanoma 57 Cimzia ® 57 Acute Myeloid Leukemia 57 CTAP# Capsules 57 posttransplant 57 rheumatic disease 57 forodesine 57 Epratuzumab 57 Myelodysplastic syndromes 57 aripiprazole Abilify 57 complement inhibitor eculizumab 57 Syndrome RLS 57 solifenacin 57 Lamotrigine 57 SomatoKine 57 sorafenib tablets 57 vWF 57 AGILECT ® 57 pancreatic insufficiency 57 thromboembolic events 57 postherpetic neuralgia PHN 57 cutaneous T 57 Cimzia ® certolizumab pegol 57 Ulcerative colitis 57 Tiotropium 57 ALA PDT 57 FOSRENOL ® 57 Aortic stenosis 57 flutamide 57 Chronic HCV 57 Follicular lymphoma 57 fructose intolerance 57 psoriasis vulgaris 57 gefitinib Iressa 57 glucocorticoid therapy 57 interstitial pneumonitis 57 cIAI 57 recurrent malignant glioma 57 lymphocytic leukemia 57 exocrine pancreatic insufficiency EPI 57 infarction NSTEMI 57 prucalopride 57 Trabectedin 57 Fludarabine 57 Nonspecific 57 inhaled corticosteroid ICS 57 lactic acidosis 57 acute myocardial infarction AMI 57 cervical lymph nodes 57 COPD exacerbations 57 hemodialysis patients 57 AST ALT 57 mTOR inhibitor 57 Myelodysplastic syndromes MDS 57 Betaferon R 57 NATRECOR R 57 histologic subtype 57 achieved CCyR 57 HMG CoA reductase inhibitor 57 chronic granulomatous disease 57 Severe Asthma 57 K ras mutations 57 de novo kidney transplant 57 weekly subcutaneous injections 57 Thal Dex 57 hyperplasia BPH 57 Patients Receiving 57 AZT zidovudine Retrovir 57 acute myelogenous leukemia AML 57 sulfasalazine 57 metastatic malignant melanoma 57 oral rivaroxaban 57 essential thrombocythemia ET 57 relapsed SCLC 57 cystic fibrosis bronchiectasis 57 ulcerative colitis 57 TEAEs 57 Psoriatic arthritis 57 CIMZIA R 57 neoadjuvant treatment 57 Alequel 57 CLL SLL 57 gastro oesophageal reflux disease 57 PEGylated anti 57 myelofibrosis polycythemia vera 57 DOXIL 57 interstitial cystitis 57 thromboembolic disease 57 cancer mCRC 57 antiarrhythmic drug 57 advanced adenoma 57 divalproex sodium 57 LymphoStat B belimumab 57 primary hypercholesterolemia 57 overactive bladder syndrome 57 receiving XGEVA 57 pegylated liposomal doxorubicin 57 olmesartan 57 Celebrex celecoxib 57 anthracyclines taxanes 57 Adenocarcinoma 57 bladder carcinoma 57 RLS sufferers 57 Iron deficiency anemia 57 acute lymphoblastic 57 VA# [002] 57 glycated hemoglobin levels 57 erythema nodosum 57 herpes zoster shingles 57 ACE Inhibitors 57 hyperprolactinemia 57 MELAS 57 MabCampath 57 non squamous NSCLC 57 dopamine partial agonist 57 SPRYCEL ® 57 stage IIIB 57 lumiliximab 57 thrombocytosis 57 placebo controlled clinical 57 Cutaneous T 57 melphalan prednisone 57 prostate cancer PCa 57 COPD exacerbation 57 Rituxan rituximab 57 idiopathic pulmonary fibrosis IPF 57 alfa 2a 57 pancreatic adenocarcinoma 57 antiproliferative effects 57 aldosterone antagonists 57 headache nasopharyngitis 57 homozygous familial hypercholesterolemia 57 pulmonary exacerbation 57 cardiac conduction 57 hematologic disorders 57 gastrointestinal adverse reactions 57 antiemetics 57 oral antidiabetic medication 57 minimally symptomatic 57 neutropenic patients 57 variceal bleeding 57 acute coronary syndromes ACS 56 hyperoxaluria 56 icatibant 56 Hypotension 56 transthyretin amyloidosis 56 AGHD 56 relapsing MS 56 Cytoxan 56 Systemic Juvenile Idiopathic 56 Platinol ® 56 debilitating complication 56 levetiracetam Keppra 56 irinotecan chemotherapy 56 aortic valve stenosis 56 certolizumab 56 PEGINTRON TM 56 pericardial effusion 56 Ophena TM 56 Adjunctive 56 Chronic Lymphocytic Leukemia CLL 56 conjunctival hyperemia 56 Surgical resection 56 sunitinib Sutent ® 56 arthropathy 56 disease modifying antirheumatic 56 mCRC patients 56 somatostatin analogs 56 nadolol 56 kidney urologic 56 node metastases 56 venlafaxine XR 56 schizophrenia CIAS 56 non hodgkin lymphoma 56 post herpetic neuralgia 56 HSCT 56 desmopressin 56 IV NSCLC 56 Temsirolimus 56 Pulmonary hypertension 56 ipratropium bromide 56 GvHD 56 dysplastic lesions 56 differentiated thyroid 56 bone marrow suppression 56 topical calcineurin inhibitors 56 dysmotility 56 bortezomib refractory 56 elevated triglyceride levels 56 Vaprisol 56 antimuscarinic 56 Nebulized 56 neuroendocrine cancers 56 Irritable bowel syndrome IBS 56 infective endocarditis 56 interferon beta therapy 56 Ziprasidone 56 BENICAR HCT 56 adenomatous 56 mTOR mammalian target 56 crizotinib PF # 56 tolterodine ER 56 hypoventilation 56 6R BH4 56 Mitoxantrone 56 severe idiopathic Restless 56 squamous cell carcinoma SCC 56 TNF alpha inhibitor 56 generalized tonic clonic seizures 56 Ischemic 56 follicular lymphomas 56 acute PAO 56 FOLFOX6 56 Major depressive disorder 56 pancreatic NET 56 previously untreated follicular 56 precancerous condition 56 Heavy menstrual bleeding 56 aspirin clopidogrel 56 GnRH agonists 56 Unstable Angina 56 esophagitis 56 polyposis 56 PEGylated Fab fragment 56 perioperatively 56 metastatic colorectal carcinoma 56 gastroduodenal 56 Nonalcoholic fatty liver 56 tinidazole 56 neovascular diseases 56 NIASPAN 56 non resectable 56 alpha interferons 56 azacytidine 56 Lung transplantation 56 DOXIL ® 56 neurologic disorder 56 receiving highly emetogenic 56 relapsed refractory multiple myeloma 56 NATRECOR ® 56 prednisone prednisolone 56 ® lenalidomide 56 INCB# [003] 56 neovascular form 56 Exacerbation 56 Fludara 56 gouty arthritis 56 Chemotherapy induced 56 mutated KRAS 56 Pulmonary Arterial Hypertension PAH 56 Allergic asthma 56 intermittent claudication 56 Perforomist Inhalation Solution 56 risperidone Risperdal 56 trans retinoic acid 56 miglustat 56 IL 1ß 56 xanthine oxidase inhibitor 56 CTAP# 56 cutaneous lupus 56 unresectable 56 detrusor overactivity 56 graft dysfunction 56 fallopian tube carcinoma 56 hepatocellular carcinomas 56 chemoradiotherapy 56 postoperative AF 56 primary hyperparathyroidism 56 Metastatic breast cancer 56 lenalidomide dexamethasone 56 constipation OIC 56 intravenous bisphosphonates 56 hepatocellular carcinoma HCC 56 indolent NHL 56 anticholinergics 56 Acute Exacerbations 56 Nesiritide 56 mg/m2 dose 56 methotrexate therapy 56 Zollinger Ellison syndrome 56 orchitis 56 CDAI 56 invasive fungal infection 56 Detrol Detrol LA 56 cirrhotic 56 factor TNF 56 imatinib Gleevec 56 venlafaxine Effexor 56 interstitial cystitis painful 56 Subarachnoid hemorrhage 56 lupus scleroderma 56 temsirolimus Torisel ® 56 Papillary 56 unresectable stage 56 metastatic carcinoid tumors 56 idebenone 56 beta 1a 56 ErbB2 positive 56 basal cell carcinoma BCC 56 heavily pretreated patients 56 post herpetic 56 severe renal impairment 56 malignant lymphomas 56 VaD 56 degenerative lumbar 56 anti muscarinic 56 Acute Myelogenous Leukemia AML 56 pseudobulbar affect PBA 56 imatinib resistance 56 Helicobacter pylori eradication 56 headache abdominal pain 56 hypertrichosis occurred 56 Oral corticosteroids 56 CYP #A# 56 carcinoid 56 PAOD 56 Denufosol 56 neutropenia dehydration dyspnea 56 reduce serum phosphate 56 recurrent acute pancreatitis 56 refractory chronic lymphocytic 56 dacarbazine 56 drug DMARD 56 chronic myeloid leukemia CML 56 Acute Coronary Syndromes ACS 56 chronic myelogenous leukemia CML 56 pancytopenia 56 hemolytic anemia 56 Abrupt discontinuation 56 induce orthostatic hypotension 56 myeloid metaplasia 56 polymyalgia 56 ALT flares 56 microvascular angina 56 Platinol ® cisplatin 56 haloperidol Haldol 56 superficial vein thrombosis 56 asthma exacerbation 56 AVONEX ® 56 cervical degenerative disc 56 Diabetic Neuropathy 56 mouse xenograft models 56 lymphoid malignancies 56 pyridostigmine 56 platelet inhibitor 56 interferon alfa 2b 56 syndrome OSAS 56 sitagliptin metformin 56 adjuvant tamoxifen 56 gastrointestinal toxicities 56 urolithiasis 56 acarbose 56 chronic ITP patients 56 recurrent ovarian cancer 56 underlying vasculopathy 56 relapsed Acute Myeloid 56 administered subcutaneously 56 HIV HCV coinfected 56 post thrombotic syndrome 56 opioid induced constipation OIC 56 adjunctive ABILIFY 56 EGFR tyrosine kinase inhibitors 56 gemcitabine Gemzar ® 56 induce remission 56 FAMPYRA 56 diabetes mellitus DM 56 OSAHS 56 Relapsing Multiple Sclerosis 56 steroid dexamethasone 56 Tarceva TM 56 Kepivance 56 nephrotoxicity 56 Telmisartan 56 subclinical hypothyroidism 56 diagnosed Ph + 56 brand ciclesonide HFA 56 circadian cytokine modulator 56 Newly Diagnosed Multiple Myeloma 56 erlotinib Tarceva 56 cranial irradiation 56 intranasal corticosteroid 56 immune modulating 56 cetuximab Erbitux R 56 myofascial pain syndrome 56 pain palliation 56 Lupus nephritis 56 etanercept Enbrel 56 dapsone 56 TACI Ig 56 Renal dysfunction 56 paragangliomas 56 leiomyomas 56 narcolepsy cataplexy 56 Raptiva R 56 anticonvulsant medications 56 primidone 56 systemic autoimmune 56 curative resection 56 nitrofurantoin 56 pegylated interferon ribavirin 56 Geodon ziprasidone 56 Uricase PEG 56 Systemic lupus erythematosus 56 Benign Prostatic Hyperplasia BPH 56 TKI therapy 56 multikinase inhibitor 56 vasomotor symptoms 56 5-FU/LV 56 VIIBRYD 56 Exacerbations 56 QTc prolongation 56 Onrigin 56 Secondary Hyperparathyroidism 56 aMCI precursor 56 NMIBC 56 AAT Deficiency 56 refractory ovarian cancer 56 QD dosing 56 PENNSAID 56 vinca alkaloid 56 underactive thyroid gland 56 TYGACIL 56 Enbrel Humira 56 severe malignant osteopetrosis 56 torsade de pointes 56 Ph + ALL 56 Atypical Hemolytic Uremic Syndrome 56 hepatic encephalopathy 56 pamidronate 56 velafermin 56 Carbaglu 56 anakinra 56 acute gout flares 56 myeloproliferative diseases 56 cough dyspnea 56 histologies 56 Seliciclib 56 Rheumatoid 56 overactive bladder symptoms 56 hepatic toxicity 56 systolic hypertension 56 adalimumab 56 hepatitis C HCV 56 heparin induced thrombocytopenia 56 dermatologic reactions 56 intracranial hemorrhage ICH 56 hematological toxicities 56 vinorelbine 56 receiving VELCADE 56 relapsed AML 56 overt nephropathy 56 thrombocytopenic patients 56 cystic fibrosis chronic pancreatitis 56 Tasigna nilotinib 56 Angioedema 56 ZYVOX 56 prostate carcinomas 56 rosuvastatin #mg 55 gastrointestinal stromal tumors GISTs 55 RRMS 55 chronic hepatitis B. 55 leukemia CML 55 Atopic eczema